SCHEMBL3842270

SCHEMBL3842270

Cc1ncc(Br)c(Br)c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ NQO2 P16083 1/20 0.38
▸ LMNA P02545 3/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA4 P22748 1/20 0.37
▸ CA6 P23280 1/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ PDXK O00764 1/20 0.36
▸ AOX1 Q06278 1/20 0.36
▸ TRIM24 O15164 1/20 0.35
▸ TRIM33 Q9UPN9 1/20 0.35
▸ VRK1 Q99986 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15322103 0.83 KDM4E (0.42) KDM4EALDH1A1HPGDHSD17B10NQO2
SCHEMBL18495782 0.81 NQO2 (0.38) KDM4EALDH1A1HPGDHSD17B10NQO2
SCHEMBL11207268 0.79 NPC1 (0.31) KDM4EALDH1A1HTTNPSR1
Bromide SCHEMBL25341248 0.79 NQO2 (0.36) KDM4EALDH1A1HPGDHSD17B10NQO2
Bromide SCHEMBL31256563 0.79 NQO2 (0.36) KDM4EALDH1A1HPGDHSD17B10NQO2
SCHEMBL7264183 0.75 LMNA (0.32) LMNA
SCHEMBL28752069 0.73 NQO2 (0.35) KDM4EALDH1A1HPGDHSD17B10NQO2
SCHEMBL31394019 0.73 KDM4E (0.44) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL18507605 0.71 HPGD (0.36) KDM4EALDH1A1HPGDHSD17B10NQO2
SCHEMBL11709612 0.71 HTT (0.43) CA1CA2CA4CA6KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022206888-A1 CDK2 INHIBITORS AND USE THEREOF QILU REGOR THERAPEUTICS INC. (CN) 2022-10-06 — — WO disclosed
EP-2686325-A1 MORPHOLINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS Vertex Pharmaceuticals Incorporated (US) 2014-01-22 — — EP disclosed
WO-2012125613-A1 MORPHOLINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-09-20 — — WO disclosed
EP-2088861-A2 BENZIMIDAZOLE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2009-08-19 — — EP disclosed
WO-2008051533-A2 BENZIMIDAZOLE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-02 — — WO disclosed
Send feedback